sulopenem   Click here for help

GtoPdb Ligand ID: 10862

Synonyms: CP-70,429 | CP-70429 | CP70429
Compound class: Synthetic organic
Comment: Sulopenem is a β-lactam (carbapenem) antibacterial [3]. It has a broad-spectrum of activity against Gram-negative, Gram-positive and anaerobic bacteria, including multi-drug resistant Gram-negative infections in both the hospital and community settings. Sulopenem is relatively stable against hydrolysis by various β-lactamases. It is being developed for oral and parenteral administration.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 164.72
Molecular weight 349.01
XLogP -0.9
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=[S@@]1CC[C@@H](C1)SC1=C(C(=O)O)N2[C@H](S1)[C@H](C2=O)[C@H](O)C
Isomeric SMILES O=[S@@]1CC[C@@H](C1)SC1=C(C(=O)O)N2[C@H](S1)[C@H](C2=O)[C@H](O)C
InChI InChI=1S/C12H15NO5S3/c1-5(14)7-9(15)13-8(11(16)17)12(20-10(7)13)19-6-2-3-21(18)4-6/h5-7,10,14H,2-4H2,1H3,(H,16,17)/t5-,6+,7+,10-,21-/m1/s1
InChI Key FLSUCZWOEMTFAQ-PRBGKLEPSA-N
References
1. Dunne MW, Aronin SI, Das AF, Akinapelli K, Breen J, Zelasky MT, Puttagunta S. (2023)
Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial.
Clin Infect Dis, 76 (1): 78-88. [PMID:36068705]
2. Kosowska-Shick K, Ednie LM, McGhee P, Appelbaum PC. (2009)
Comparative antipneumococcal activities of sulopenem and other drugs.
Antimicrob Agents Chemother, 53 (6): 2239-47. [PMID:19307366]
3. Minamimura M, Taniyama Y, Inoue E, Mitsuhashi S. (1993)
In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.
Antimicrob Agents Chemother, 37 (7): 1547-51. [PMID:8363389]
4. Okamoto K, Gotoh N, Nishino T. (2001)
Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
Antimicrob Agents Chemother, 45 (7): 1964-71. [PMID:11408209]
5. thepharmaletter team. 
Iterum hopeful despite Phase III miss for sulopenem.
Accessed on 12/05/2020. Modified on 12/05/2020. thepharmaletter.com, https://www.thepharmaletter.com/article/iterum-hopeful-despite-phase-iii-miss-for-sulopenem